Xolair (omalizumab)

omalizumab · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Xolair (omalizumab), covering 2008-06-04 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Short Treatment with Omalizumab for Severe Asthma [Phase 4]